Danger in the intensive care unit: Damps in critically ill patients

Shock

Volumn 45, Issue 2, 2016, Pages 108-116

  Timmermans, Kim ^a   Kox, Matthijs ^a   Scheffer, Gert Jan ^a   Pickkers, Peter ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac arrest; Danger signals; HMGB1; hSP70; S100 Proteins; Sepsis; Trauma; Ventilator Induced Lung Injury

Indexed keywords

DANGER ASSOCIATED MOLECULAR PATTERN; HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; HYALURONIC ACID; NUCLEIC ACID; PROTEIN; PROTEIN S 100; UNCLASSIFIED DRUG; ALARMIN; BIOLOGICAL MARKER;

CRITICALLY ILL PATIENT; ENDOTOXEMIA; HEART ARREST; HUMAN; INJURY; INTENSIVE CARE UNIT; MOLECULAR MECHANICS; NONHUMAN; PROGNOSIS; PROTEIN SECRETION; REVIEW; SEPSIS; VENTILATOR INDUCED LUNG INJURY; CRITICAL ILLNESS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM;

ALARMINS; BIOMARKERS; CRITICAL ILLNESS; HEAT-SHOCK PROTEINS; HMGB1 PROTEIN; HUMANS; HYALURONIC ACID; IMMUNITY, INNATE; INTENSIVE CARE UNITS; S100 PROTEINS;

EID: 84957800416     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000506     Document Type: Review

References (69)

1. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 12:991-1045, 1994.
2. Matzinger P: The danger model: a renewed sense of self. Science 296(5566):301-305, 2002.
3. Oppenheim JJ, Yang D: Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 17(4):359-365, 2005.
4. Kono H, Rock KL: How dying cells alert the immune system to danger. Nat Rev Immunol 8(4):279-289, 2008.
5. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al.: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285(5425):248-251, 1999.
6. Gibot S, Massin F, Cravoisy A, Barraud D, Nace L, Levy B, Bollaert PE: Highmobility group box 1 protein plasma concentrations during septic shock. Intensive Care Med 33(8):1347-1353, 2007.
7. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, Tracey KJ, Lee ML, Andersson J, Tokics L, Treutiger CJ: Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 33(3):564-573, 2005.
8. Zhang R, Wan XJ, Zhang X, Kang QX, Bian JJ, Yu GF, Wang JF, Zhu KM: Plasma HSPA12B is a potential predictor for poor outcome in severe sepsis. PLoS One 9(6):e101215, 2014.
9. Ramakrishna K, Pugazhendhi S, Kabeerdoss J, Peter JV: Association between heat shock protein 70 gene polymorphisms and clinical outcomes in intensive care unit patients with sepsis. Indian J Crit Care Med 18(4):205-211, 2014.
10. van Zoelen MA, Vogl T, Foell D, Van Veen SQ, van Till JW, Florquin S, Tanck MW, Wittebole X, Laterre PF, Boermeester MA, et al.: Expression and role of myeloid-related protein-14 in clinical and experimental sepsis. Am J Respir Crit Care Med 180(11):1098-1106, 2009.
11. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, et al.: Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13(9):1042-1049, 2007.
12. Puskarich MA, Shapiro NI, Trzeciak S, Kline JA, Jones AE: Plasma levels of mitochondrial DNA in patients presenting to the emergency department with sepsis. Shock 38(4):337-340, 2012.
13. Cohen MJ, Brohi K, Calfee CS, Rahn P, Chesebro BB, Christiaans SC, Carles M, Howard M, Pittet JF: Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit Care 13(6):R174, 2009.
14. Levy RM, Mollen KP, Prince JM, Kaczorowski DJ, Vallabhaneni R, Liu S, Tracey KJ, Lotze MT, Hackam DJ, Fink MP, et al.: Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regul Integr Comp Physiol 293(4):R1538-R1544, 2007.
15. Yang R, Harada T, Mollen KP, Prince JM, Levy RM, Englert JA, Gallowitsch-Puerta M, Yang L, Yang H, Tracey KJ, et al.: Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med 12(4-6):105-114, 2006.
16. Kim JY, Park JS, Strassheim D, Douglas I, Diaz del Valle F, Asehnoune K, Mitra S, Kwak SH, Yamada S, Maruyama I, et al.: HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 288(5):L958-L965, 2005.
17. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, et al.: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201(7):1135-1143, 2005.
18. Pittet JF, Lee H, Morabito D, Howard MB, Welch WJ, Mackersie RC: Serum levels of Hsp 72 measured early after trauma correlate with survival. J Trauma 52(4):611-617, 2002.
19. Chernov AV, Dolkas J, Hoang K, Angert M, Srikrishna G, Vogl T, Baranovskaya S, Strongin AY, Shubayev VI: The calcium-binding proteins S100A8 and S100A9 initiate the early inflammatory program in injured peripheral nerves. J Biol Chem 290(18):11771-11784, 2015.
20. Edsberg L E, Wyffels F , Ogrin R, Craven C, Houghton P: A pilot study evaluating protein abundance in pressure ulcer fluid from people with and without spinal cord injury. J Spinal Cord Med 38(4):456-467, 2014.
21. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ: Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464(7285):104-107, 2010.
22. van Zoelen MA, Ishizaka A, Wolthuls EK, Choi G, van der Poll T, Schultz MJ: Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia. Shock 29(4):441-445, 2008.
23. Ogawa EN, Ishizaka A, Tasaka S, Koh H, Ueno H, Amaya F, Ebina M, Yamada S, Funakoshi Y, Soejima J, et al.: Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury. Am J Respir Crit Care Med 174(4):400-407, 2006.
24. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ: HMG-1 as a mediator of acute lung inflammation. J Immunol 165(6):2950-2954, 2000.
25. Ganter MT,Ware LB, Howard M, Roux J, Gartland B, Matthay MA, Fleshner M, Pittet JF: Extracellular heat shock protein 72 is a marker of the stress protein response in acute lung injury. Am J Physiol Lung Cell Mol Physiol 291(3):L354-L361, 2006.
26. Chase MA, Wheeler DS, Lierl KM, Hughes VS, Wong HR, Page K: Hsp72 induces inflammation and regulates cytokine production in airway epithelium through a TLR4-and NF-kappaB-dependent mechanism. J Immunol 179(9):6318-6324, 2007.
27. Wittkowski H, Sturrock A, van Zoelen MA, Viemann D, van der Poll T, Hoidal JR, Roth J, Foell D: Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit Care Med 35(5):1369-1375, 2007.
28. Lorenz E, Muhlebach MS, Tessier PA, Alexis NE, Duncan Hite R, Seeds MC, Peden DB, MeredithW: Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases. Respir Med 102(4):567-573, 2008.
29. Davidson BA, Vethanayagam RR, Grimm MJ, Mullan BA, Raghavendran K, Blackwell TS, Freeman ML, Ayyasamy V, Singh KK, Sporn MB, et al.: NADPH oxidase and Nrf2 regulate gastric aspiration-induced inflammation and acute lung injury. J Immunol 190(4):1714-1724, 2013.
30. Zhang JZ, Liu Z, Liu J, Ren JX, Sun TS: Mitochondrial DNA induces inflammation and increases TLR9/NF-kappaB expression in lung tissue. Int J Mol Med 33(4):817-824, 2014.
31. Gu X, Wu G, Yao Y, Zeng J, Shi D, Lv T, Luo L, Song##Y: Intratracheal administration of mitochondrial DNA directly provokes lung inflammation through the TLR9-p38 MAPK pathway. Free Radic Biol Med 83:149-158, 2015.
32. Oda Y, Tsuruta R, Fujita M, Kaneda K, Kawamura Y, Izumi T, Kasaoka S, Maruyama I, Maekawa T: Prediction of the neurological outcome with intrathecal high mobility group box 1 and S100B in cardiac arrest victims: a pilot study. Resuscitation 83(8):1006-1012, 2012.
33. Limana F, Germani A, Zacheo A, Kajstura J, Di Carlo A, Borsellino G, Leoni O, Palumbo R, Battistini L, Rastaldo R, et al.: Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res 97(8):e73-e83, 2005.
34. Timmermans K, Kox M, Gerretsen J, Peters E, Scheffer GJ, van der Hoeven JG, Pickkers P, Hoedemaekers CW: The involvement of danger-associated molecular patterns in the development of immunoparalysis in cardiac arrest patients. Crit Care Med 43(11):2332-2338, 2015.
35. Rohde D, Schon C, Boerries M, Didrihsone I, Ritterhoff J, Kubatzky KF, Volkers M, Herzog N, Mahler M, Tsoporis JN, et al.: S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4. EMBO Mol Med 6(6):778-794, 2014.
36. Fernandez-Ruiz I, Arnalich F, Cubillos-Zapata C, Hernandez-Jimenez E, Moreno-Gonzalez R, Toledano V, Fernandez-Velasco M, Vallejo-Cremades MT, Esteban-Burgos L, de Diego RP, et al.: Mitochondrial DAMPs induce endotoxin tolerance in human monocytes: an observation in patients with myocardial infarction. PLoS One 9(5):e95073, 2014.
37. Dybdahl B, Slordahl SA,Waage A, Kierulf P, Espevik T, Sundan A: Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart 91(3):299-304, 2005.
38. Yokobori S, Hosein K, Burks S, Sharma I, Gajavelli S, Bullock R: Biomarkers for the clinical differential diagnosis in traumatic brain injury: a systematic review. CNS Neurosci Ther 19(8):556-565, 2013.
39. Lam NY, Rainer TH, Chiu RW, Joynt GM, Lo YM: Plasma mitochondrial DNA concentrations after trauma. Clin Chem 50(1):213-216, 2004.
40. Singleton KD, Serkova N, Beckey VE, Wischmeyer PE: Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression. Crit Care Med 33(6):1206-1213, 2005.
41. Chang YC, Tsai MH, Sheu WH, Hsieh SC, Chiang AN: The therapeutic potential and mechanisms of action of quercetin in relation to lipopolysaccharide-induced sepsis in vitro and in vivo. PLoS One 8(11):e80744, 2013.
42. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, Zeh HJ, et al.: Endogenous HMGB1 regulates autophagy. J Cell Biol 190(5):881-892, 2010.
43. Scaffidi P, Misteli T, Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418(6894):191-195, 2002.
44. Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A: HMGB1: endogenous danger signaling. Mol Med 14(7-8):476-484, 2008.
45. Foell D,Wittkowski H, Vogl T, Roth J: S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 81(1):28-37, 2007.
46. Ellis EF,Willoughby KA, Sparks SA, Chen T: S100B protein is released from rat neonatal neurons, astrocytes, and microglia by in vitro trauma and anti-S100 increases trauma-induced delayed neuronal injury and negates the protective effect of exogenous S100B on neurons. J Neurochem 101(6):1463-1470, 2007.
47. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C: Myeloidrelated protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 272(14):9496-9502, 1997.
48. Bianchi ME: DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81(1):1-5, 2007.
49. Bianchi R, Adami C, Giambanco I, Donato R: S100B binding to RAGE in microglia stimulates COX-2 expression. J Leukoc Biol 81(1):108-118, 2007.
50. Feng H, Zeng Y, Graner MW, Likhacheva A, Katsanis E: Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity. Blood 101(1):245-252, 2003.
51. Hunter-Lavin C, Davies EL, Bacelar MM, Marshall MJ, Andrew SM, Williams JH: Hsp70 release from peripheral blood mononuclear cells. Biochem Biophys Res Commun 324(2):511-517, 2004.
52. Dybdahl B, Wahba A, Lien E, Flo TH, Waage A, Qureshi N, Sellevold OF, Espevik T, Sundan A: Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation 105(6):685-690, 2002.
53. Arnold-Schild D, Hanau D, Spehner D, Schmid C, Rammensee HG, de la Salle H, Schild H: Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol 162(7):3757-3760, 1999.
54. Tang D, Kang R, Xiao W, Jiang L, Liu M, Shi Y, Wang K, Wang H, Xiao X: Nuclear heat shock protein 72 as a negative regulator of oxidative stress (hydrogen peroxide)-induced HMGB1 cytoplasmic translocation and release. J Immunol 178(11):7376-7384, 2007.
55. Jounai N, Kobiyama K, Takeshita F, Ishii KJ: Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination. Front Cell Infect Microbiol 2:168, 2012.
56. Kariko K, Ni H, Capodici J, Lamphier M,Weissman D: mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279(13):12542-12550, 2004.
57. Beyer C, Stearns NA, Giessl A, Distler JH, Schett G, Pisetsky DS: The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death. Innate Immun 18(5):727-737, 2012.
58. Bourguignon LY, Wong G, Earle CA, Xia W: Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFkappaB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion. Cytoskeleton (Hoboken) 68(12):671-693, 2011.
59. Timmers L, Pasterkamp G, de Hoog VC, Arslan F, Appelman Y, de Kleijn DP: The innate immune response in reperfused myocardium. Cardiovasc Res 94(2):276-283, 2012.
60. Sursal T, Stearns-Kurosawa DJ, Itagaki K, Oh SY, Sun S, Kurosawa S, Hauser CJ: Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates. Shock 39(1):55-62, 2013.
61. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, et al.: Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 101(1):296-301, 2004.
62. Bhagirath VC, Dwivedi DJ, Liaw PC: Comparison of the pro-inflammatory and pro-coagulant properties of nuclear, mitochondrial, and bacterial DNA. Shock 44(3):265-271, 2015.
63. Mai SH, Khan M, Dwivedi DJ, Ross CA, Zhou J, Gould TJ, Gross PL,Weitz JI, Fox-Robichaud AE, Liaw PC, Canadian Critical Care Translational Biology G. Delayed but not early treatment with DNase reduces organ damage and improves outcome in a murine model of sepsis. Shock 44(2):166-172, 2015.
64. Nelson A, Berkestedt I, Bodelsson M: Circulating glycosaminoglycan species in septic shock. Acta Anaesthesiol Scand 58(1):36-43, 2014.
65. Liu YY, Lee CH, Dedaj R, Zhao H, Mrabat H, Sheidlin A, Syrkina O, Huang PM, Garg HG, Hales CA, et al.: High-molecular-weight hyaluronan: a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats. Crit Care 12(4):R102, 2008.
66. Wang J, Vodovotz Y, Fan L, Li Y, Liu Z, Namas R, Barclay D, Zamora R, Billiar TR, Wilson MA, et al.: Injury-induced MRP8/MRP14 stimulates IP-10/CXCL10 in monocytes/macrophages. FASEB J 29(1):250-262, 2015.
67. Rahbar E, Cardenas JC, Baimukanova G, Usadi B, Bruhn R, Pati S, Ostrowski SR, Johansson PI, Holcomb JB,WadeCE:Endothelial glycocalyx shedding and vascular permeability in severely injured trauma patients. J Transl Med 13:117, 2015.
68. Hallgren R, Samuelsson T, Laurent TC, Modig J: Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome. Am Rev Respir Dis 139(3):682-687, 1989.
69. Mrabat H, Beagle J, Hang Z, Garg HG, Hales CA, Quinn DA: Inhibition of HA synthase 3 mRNA expression, with a phosphodiesterase 3 inhibitor, blocks lung injury in a septic ventilated rat model. Lung 187(4):233-239, 2009.